Escherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated

Product Details
Customization: Available
Varieties: Vaccine
Component: Virus
Still deciding? Get samples of US$ 0.01/Sample
Order Sample
Shipping & Policy
Shipping Cost: Contact the supplier about freight and estimated delivery time.
Payment methods: visa mastercard discover JCB diners club american express T/T
  Support payment in USD
Secure payments: Every payment you make at Made-in-china.com is protected by the platform.
Refund policy: Claim a refund if your order doesn't ship, is missing, or arrives with product issues.
Manufacturer/Factory & Trading Company

360° Virtual Tour

Secured Trading Service
Diamond Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
1200
Year of Establishment
1999-04-02
  • Escherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated
  • Escherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated
Find Similar Products
  • Overview
  • Product Description
Overview

Basic Info.

Model NO.
02
Pharmacodynamic Influential Factors
Virus
Storage Method
Prevent High or LowTemperature
Veterinary Reg. No.
154391028
Usage
Administer Via Intramuscular Injection in The Neck
Shelf Life
12 Months
Temperature
Store at 4-8ºC
Withdrawal Period
0 Day
Package
(1) 300 Bottles/Carton ; 1000 Bottles/Carton
Transport Package
Air Way/Sea Way
Specification
10 ml/bottle; 40 ml/bottle
Trademark
SINDER
Origin
China
Production Capacity
100000L/Year

Packaging & Delivery

Package Size
61.20cm * 34.50cm * 41.00cm
Package Gross Weight
20.000kg

Product Description

Product Description

Escherichia Coli Trivalent Vaccine for Newborn Piglets, InactivatedGENERIC NAME:
Escherichia coli Trivalent Vaccine for Newborn Piglets, Inactivated.
COMPOSITION:
The vaccine contains Escherichia coli with K88, K99, and 987P fimbrial antigens, with reverse indirect hemagglutination (RIHA) titers for the three fimbrial antigens. The titers for K88 and K99 are both ≥40 times, and for 987P, it is ≥160 times.
CHARACTERISTIC:
After standing still, the upper layer is a clear, white liquid, and the lower layer is a milky white precipitate. After shaking, it forms a uniform suspension.
INDICATION(S):
The product is used for immunizing pregnant sows so that passive immunity can be obtained by newborn piglets through suckling the mother's colostrum. This vaccine is intended for the prevention of colibacillosis in piglets (neonatal piglet diarrhea).
ADMINISTRATION AND DOSAGE:
For pregnant sows, administer one injection 40 days and another 15 days before delivery, with each injection being 5ml via intramuscular injection.
6. HILE- Escherichia coli Trivalent Vaccine for Newborn Piglets, Inactivated
(1) Advanced purification technology to produce high-putrity.
(2) The product contains K88, K99 and 987P antigens, which is effective again yellow and white scour of piglets.
(3) Medical grade aluminum glue adjuvant ensures that the vaccine is easy to be suckd out and injected.
Escherichia Coli Trivalent Vaccine for Newborn Piglets, InactivatedEscherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated
Escherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.Escherichia Coli Trivalent Vaccine for Newborn Piglets, InactivatedEscherichia Coli Trivalent Vaccine for Newborn Piglets, InactivatedEscherichia Coli Trivalent Vaccine for Newborn Piglets, InactivatedEscherichia Coli Trivalent Vaccine for Newborn Piglets, Inactivated

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier